Literature DB >> 23177595

Higher iron in the red nucleus marks Parkinson's dyskinesia.

Mechelle M Lewis1, Guangwei Du, Michal Kidacki, Nisargkumar Patel, Michele L Shaffer, Richard B Mailman, Xuemei Huang.   

Abstract

Dopamine cell loss and increased iron in the substantia nigra (SN) characterize Parkinson's disease (PD), with cerebellar involvement increasingly recognized, particularly in motor compensation and levodopa-induced dyskinesia (LID) development. Because the red nucleus (RN) mediates cerebellar circuitry, we hypothesized that RN iron changes might reflect cerebellum-related compensation, and/or the intrinsic capacity for LID development. We acquired high resolution magnetic resonance images from 23 control and 38 PD subjects (12 with PD and history of LID [PD+DYS]) and 26 with PD and no history of LID (PD-DYS). Iron content was estimated from bilateral RN and SN transverse relaxation rates (R2*). PD subjects overall displayed higher R2* values in both the SN and RN. RN R2* values correlated with off-drug Unified Parkinson's Disease Rating Scale-motor scores, but not disease duration or drug dosage. RN R2* values were significantly higher in PD+DYS compared with control and PD-DYS subjects; control and PD-DYS subjects did not differ. The association of higher RN iron content with PD-related dyskinesia suggests increased iron content is involved in, or reflects, greater cerebellar compensatory capacity and thus increased likelihood of LID development.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177595      PMCID: PMC3570638          DOI: 10.1016/j.neurobiolaging.2012.10.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  47 in total

1.  The cerebellum communicates with the basal ganglia.

Authors:  Eiji Hoshi; Léon Tremblay; Jean Féger; Peter L Carras; Peter L Strick
Journal:  Nat Neurosci       Date:  2005-10-02       Impact factor: 24.884

Review 2.  Learning to predict the future: the cerebellum adapts feedforward movement control.

Authors:  Amy J Bastian
Journal:  Curr Opin Neurobiol       Date:  2006-10-30       Impact factor: 6.627

3.  Task-dependent compensation after pyramidal tract and dorsolateral spinal lesions in rats.

Authors:  Srikanth G Kanagal; Gillian D Muir
Journal:  Exp Neurol       Date:  2008-12-11       Impact factor: 5.330

4.  Internal models in the cerebellum.

Authors:  D M Wolpert; R C Miall; M Kawato
Journal:  Trends Cogn Sci       Date:  1998-09-01       Impact factor: 20.229

5.  Neurochemical significance of the red nucleus.

Authors:  D Nieto; A Nieto
Journal:  Bull Clin Neurosci       Date:  1986

Review 6.  The transition metals copper and iron in neurodegenerative diseases.

Authors:  Susana Rivera-Mancía; Iván Pérez-Neri; Camilo Ríos; Luis Tristán-López; Liliana Rivera-Espinosa; Sergio Montes
Journal:  Chem Biol Interact       Date:  2010-05-14       Impact factor: 5.192

7.  Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.

Authors:  M M Lewis; G Du; S Sen; A Kawaguchi; Y Truong; S Lee; R B Mailman; X Huang
Journal:  Neuroscience       Date:  2011-01-04       Impact factor: 3.590

8.  Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Journal:  Ann Neurol       Date:  2011-01-18       Impact factor: 10.422

9.  Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.

Authors:  G Koch; L Brusa; F Carrillo; E Lo Gerfo; S Torriero; M Oliveri; P Mir; C Caltagirone; P Stanzione
Journal:  Neurology       Date:  2009-07-14       Impact factor: 9.910

Review 10.  The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease.

Authors:  Dag Nyholm
Journal:  Parkinsonism Relat Disord       Date:  2007-08-17       Impact factor: 4.891

View more
  26 in total

1.  Frequency-dependent neural activity in Parkinson's disease.

Authors:  Yanan Hou; Xuemin Wu; Mark Hallett; Piu Chan; Tao Wu
Journal:  Hum Brain Mapp       Date:  2014-07-12       Impact factor: 5.038

Review 2.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

3.  Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults.

Authors:  Wei Li; Christian Langkammer; Ying-Hui Chou; Katja Petrovic; Reinhold Schmidt; Allen W Song; David J Madden; Stefan Ropele; Chunlei Liu
Journal:  Neuroimage       Date:  2014-10-12       Impact factor: 6.556

Review 4.  Dyskinesias and levodopa therapy: why wait?

Authors:  Michele Matarazzo; Alexandra Perez-Soriano; A Jon Stoessl
Journal:  J Neural Transm (Vienna)       Date:  2018-02-10       Impact factor: 3.575

Review 5.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

6.  Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.

Authors:  G Du; M M Lewis; S Kanekar; N W Sterling; L He; L Kong; R Li; X Huang
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-31       Impact factor: 3.825

7.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.

Authors:  Xiaojun Guan; Min Xuan; Quanquan Gu; Peiyu Huang; Chunlei Liu; Nian Wang; Xiaojun Xu; Wei Luo; Minming Zhang
Journal:  NMR Biomed       Date:  2016-02-08       Impact factor: 4.044

8.  A multicontrast approach for comprehensive imaging of substantia nigra.

Authors:  Jason Langley; Daniel E Huddleston; Xiangchuan Chen; Jan Sedlacik; Nishant Zachariah; Xiaoping Hu
Journal:  Neuroimage       Date:  2015-02-28       Impact factor: 6.556

Review 9.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

10.  Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

Authors:  Naying He; Pei Huang; Huawei Ling; Jason Langley; Chunlei Liu; Bei Ding; Juan Huang; Hongmin Xu; Yong Zhang; Zhongping Zhang; Xiaoping Hu; Shengdi Chen; Fuhua Yan
Journal:  NMR Biomed       Date:  2016-05-18       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.